Some Traders Attributing Move Lower In Intercept Pharma To Doc From Co.'s Chief Medical Officer To Health Care Providers Highlighting Seemingly Negative Postmarketing Cases For Its OCALIVA; However, Doc Is Dated Sept. 8, 2017
Paul Quintaro